PI

Professor Itescu

Mesoblast Limited | Chief Executive Officer, Executive Director
Dr Itescu has been a faculty member of Columbia University in New York, and the University of Melbourne and Monash University in Australia. Dr Itescu has consulted for various international pharmaceutical companies, has been an adviser to biotechnology and health care investor groups, and has served on the board of directors of several publicly listed life sciences companies. He is the member of the Clinical Committee Member.

Company and Roles

Company
Title
Tenure
Since
MSB
MSB
Mesoblast Limited
  • Chief Executive Officer
  • Executive Director
22yrs, 4mthJun 2004

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
MSB
MSB
Mesoblast Limited
17/07/2669,642,17211,202,09016,311,253N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
MSB
MSB
Mesoblast Limited
17/07/26
Exercise
1,885,334$1.450$2,733,734Exercise of options
MSB
MSB
Mesoblast Limited
17/07/26
Buy
1,885,334$1.450$2,733,734Exercise of options
MSB
MSB
Mesoblast Limited
07/07/26
Expiry
278,571$2.040$568,284Options expired
MSB
MSB
Mesoblast Limited
17/03/26
Issued
2,025,600$2.020$4,091,712Issue of options
MSB
MSB
Mesoblast Limited
01/04/25
Issued
3,108,000$1.935$6,013,980Issue of options